MyFinsight
Home
Blog
About
Maturities of marketable
securities
$119,561K
Proceeds from exercise of
stock options
$66K
Net cash provided by
(used in) investing...
$92,997K
Net cash provided by
financing activities
$66K
Canceled cashflow
$26,564K
Net decrease in
cash, cash...
-$3,510K
Canceled cashflow
$93,063K
Stock-based compensation
$11,388K
Depreciation and
amortization
$2,255K
Accounts payable
$1,872K
Amortization of operating
lease right-of-use...
$1,595K
Prepaid expenses and
other assets
-$263K
Purchases of marketable
securities
$24,628K
Purchases of property and
equipment
$1,936K
Net cash used in
operating activities
-$96,573K
Canceled cashflow
$17,373K
Net loss
-$89,535K
Accrued expenses and
other current...
-$15,253K
Deferred revenue
-$7,044K
Net accretion of
discount on marketable...
$1,557K
Operating lease
liabilities
-$557K
Back
Back
Cash Flow
Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX)
source: myfinsight.com